Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

candesartan cilexetil MeSH Supplementary Concept Data 2026


MeSH Supplementary
candesartan cilexetil
Unique ID
C077793
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C077793
Entry Term(s)
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1H-benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)-
Amias
Atacand
Blopress
Kenzen
Parapres
TCV 116
TCV-116
Pharm Action
Antihypertensive Agents
Angiotensin II Type 1 Receptor Blockers
Registry Numbers
R85M2X0D68
Related Numbers
145040-37-5
Heading Mapped to
*Benzimidazoles
*Biphenyl Compounds
*Tetrazoles
Frequency
609
Note
a prodrug which is metabolized to an active form candesartan to exert its biological effects
Source
Life Sci 1992;51(20):PL-183-7
Date Introduced
1992/12/03
Last Updated
2021/02/18
candesartan cilexetil Preferred
TCV 116 Narrower
Atacand Narrower
Parapres Narrower
Amias Narrower
Blopress Narrower
Kenzen Narrower
page delivered in 0.005s